Literature DB >> 8651298

Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: cellular population-dependent dynamics of mitotic instability.

H Takano1, O Onodera, H Takahashi, S Igarashi, M Yamada, M Oyake, T Ikeuchi, R Koide, H Tanaka, K Iwabuchi, S Tsuji.   

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disease caused by unstable expansion of a CAG repeat in the DRPLA gene. We performed detailed quantitative analysis of the size and the size distribution (range) of the expanded CAG repeats in various regions of the CNS of eight autopsied patients with DRPLA. Expanded alleles (AE) showed considerable variations in size, as well as in range, depending on the region of the CNS, whereas normal alleles did not show such variations, which indicates the occurrence of somatic mosaicism of AE in the CNS. The AE in the cerebellar cortex were consistently smaller by two to five repeat units than those in the cerebellar white matter. Moreover, the AE in the cerebral cortex were smaller by one to four repeat units than those in the cerebral white matter. These results suggest that the smaller AE in the cerebellar and cerebral cortices represent those of neuronal cells. The ranges of the AE in the cerebral cortex, cerebral white matter, and cerebellar white matter showed considerable variation ranging from 9 to 23 repeat units, whereas those in the cerebellar cortex showed little variance and were approximately 7 repeat units. The ranges of the AE in the cerebral cortex, cerebral white matter, and cerebellar white matter were much broader in patients with higher ages at death than they were in patients with lower ages at death, raising the possibility that the range of AE increases with time, as the result of mitotic instability of AE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651298      PMCID: PMC1915058     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  35 in total

1.  CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain.

Authors:  N Aronin; K Chase; C Young; E Sapp; C Schwarz; N Matta; R Kornreich; B Landwehrmeyer; E Bird; M F Beal
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

2.  [Study on two autopsied cases of degenerative type of myoclonus epilepsy with choreo-athetoid movement: Proposal of hereditary dentate and pallidal system atrophy (author's transl)].

Authors:  H Naito; M Tanaka; Y Hirose; S Oyanagi
Journal:  Seishin Shinkeigaku Zasshi       Date:  1977

3.  Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain.

Authors:  I Yazawa; N Nukina; H Hashida; J Goto; M Yamada; I Kanazawa
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

4.  Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.

Authors:  Y Trottier; D Devys; G Imbert; F Saudou; I An; Y Lutz; C Weber; Y Agid; E C Hirsch; J L Mandel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

5.  Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients.

Authors:  O C Stine; S H Li; N Pleasant; M V Wagster; J C Hedreen; C A Ross
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

6.  Expression of the Huntington's disease (IT15) protein product in HD patients.

Authors:  G Schilling; A H Sharp; S J Loev; M V Wagster; S H Li; O C Stine; C A Ross
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

7.  Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1.

Authors:  S S Chong; A E McCall; J Cota; S H Subramony; H T Orr; M R Hughes; H Y Zoghbi
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

8.  Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

Authors:  C A Gutekunst; A I Levey; C J Heilman; W L Whaley; H Yi; N R Nash; H D Rees; J J Madden; S M Hersch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS.

Authors:  O Onodera; M Oyake; H Takano; T Ikeuchi; S Igarashi; S Tsuji
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

10.  Widespread expression of Huntington's disease gene (IT15) protein product.

Authors:  A H Sharp; S J Loev; G Schilling; S H Li; X J Li; J Bao; M V Wagster; J A Kotzuk; J P Steiner; A Lo
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

View more
  23 in total

Review 1.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.

Authors:  Marka van Blitterswijk; Mariely DeJesus-Hernandez; Ellis Niemantsverdriet; Melissa E Murray; Michael G Heckman; Nancy N Diehl; Patricia H Brown; Matthew C Baker; NiCole A Finch; Peter O Bauer; Geidy Serrano; Thomas G Beach; Keith A Josephs; David S Knopman; Ronald C Petersen; Bradley F Boeve; Neill R Graff-Radford; Kevin B Boylan; Leonard Petrucelli; Dennis W Dickson; Rosa Rademakers
Journal:  Lancet Neurol       Date:  2013-09-05       Impact factor: 44.182

3.  Modifiers of (CAG)(n) instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes.

Authors:  Sandra Martins; Christopher E Pearson; Paula Coutinho; Sylvie Provost; António Amorim; Marie-Pierre Dubé; Jorge Sequeiros; Guy A Rouleau
Journal:  Hum Genet       Date:  2014-07-16       Impact factor: 4.132

4.  Exclusion of CAG repeat expansion as the cause of disease in autosomal dominant retinitis pigmentosa families.

Authors:  T J Keen; A G Morris; C F Inglehearn
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

5.  Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients.

Authors:  P Maciel; I Lopes-Cendes; S Kish; J Sequeiros; G A Rouleau
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA).

Authors:  Y Ito; F Tanaka; M Yamamoto; M Doyu; M Nagamatsu; S Riku; T Mitsuma; G Sobue
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

Review 7.  Molecular pathology of dentatorubral-pallidoluysian atrophy.

Authors:  I Kanazawa
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

8.  Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions.

Authors:  Christopher E Pearson; Mandy Tam; Yuh-Hwa Wang; S Erin Montgomery; Arvin C Dar; John D Cleary; Kerrie Nichol
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

9.  DNA instability in replicating Huntington's disease lymphoblasts.

Authors:  Milena Cannella; Vittorio Maglione; Tiziana Martino; Giuseppe Ragona; Luigi Frati; Guo-Min Li; Ferdinando Squitieri
Journal:  BMC Med Genet       Date:  2009-02-11       Impact factor: 2.103

10.  Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age.

Authors:  Amanda G Mason; Stephanie Tomé; Jodie P Simard; Randell T Libby; Theodor K Bammler; Richard P Beyer; A Jennifer Morton; Christopher E Pearson; Albert R La Spada
Journal:  Hum Mol Genet       Date:  2013-11-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.